ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

ACCC Considers Role Of Allied Personnel, Funds, Center Components

February 13, 1976

Senators Call Mammography Debate Confusing, Say Screening “Saves Lives”.

March 8, 2002

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976